Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital
Abstract
The University of Kentucky Hospital investigated the feasibility of choosing a sole fluoroquinolone for its formulary in an effort to reduce costs without affecting clinical outcomes. A three-step process was used to plan, implement, and monitor the selection program. Based on the range of clinical …
Keywords
University
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
anti-bacterial agents / therapeutic use
bacteria / drug effects
anti-bacterial agents / adverse effects
fluoroquinolones / therapeutic use
microbial sensitivity tests
ciprofloxacin / therapeutic use
hospitals
levofloxacin*
drug costs
ciprofloxacin / pharmacokinetics
ofloxacin / pharmacokinetics
pmid:15119984
doi:10.1185/030079904125003223
robert p rapp
martin e evans
john a armitstead
anti-bacterial agents / economics*
anti-bacterial agents / pharmacokinetics
ciprofloxacin / adverse effects
ciprofloxacin / economics
cost savings
fluoroquinolones / adverse effects
fluoroquinolones / economics*
fluoroquinolones / pharmacokinetics
formularies
hospital as topic*
hospital costs
ofloxacin / adverse effects
ofloxacin / economics*
ofloxacin / therapeutic use
organizational policy
Access
Citation
ID:
112609
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112609
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
